Home Page - Slider

Reproductive Testing
Genetic Counseling
informaSeq Prenatal Test
VistaSeqSM Hereditary Cancer Testing

For Patients

Prepare for visits with your doctor or a genetic counselor by learning about testing.

Working with Integrated Genetics

Integrated Genetics Highlights

“Sequenom’s proven best-in-class technology and strong research complement LabCorp’s extensive women’s health offering, providing patients and physicians with one source for the most complete range of testing options in women’s health, including NIPT and reproductive genetics”, Dave P. King, Chairman and CEO of LabCorp.

On July 28th the American College of Medical Genetics and Genomics (ACMG) released an updated statement that highlights the information health care providers should discuss with patients when considering prenatal aneuploidy screening options.  To read position statement, please visit http://www.nature.com/gim/journal/vaop/ncurrent/pdf/gim201697a.pdf

Now the Largest Open BRCA Datashare of Curated BRCA Variants Clinically Suitable for Patient Management 

​A comprehensive suite of testing options to identify BRCA 1 and 2 mutations associated with breast, ovarian and certain other cancers.

Analysis of over 7,400 mutations found in 142 different genes, associated with more than 114 different inherited diseases

An assessment of genetic mutations within a panel of 27 genes known to be associated with hereditary cancer syndromes. 

An advanced, non-invasive prenatal screening for T21, T18, and T13 chromosomal aneuploidies using next generation technology that can be administered as early as 10 weeks gestation.